Status:
RECRUITING
Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry
Lead Sponsor:
Centre hospitalier de Ville-Evrard, France
Conditions:
Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Since psychiatry is still too often confronted with a dichotomy between psyche and soma, the assessment of pain and anxiety at RMI is still rarely done (Willer et al., 1982). The objective of this exp...
Eligibility Criteria
Inclusion
- Patients (Males, Females)
- Over the age of 18
- Hospitalized or outpatient
- Patient affiliated with social security, State Medical Aid (AME)
- With prescription of antipsychotic delay by intramuscular injection
- French language mastered
- Given oral consent to pass the self-assessment scales
Exclusion
- Patients on long-term analgesic treatment, daily
- Patients with chronic pain with or without analgesic treatment
- Patient not communicating
- Pregnant woman, parturint and nursing mother
- Person deprived of liberty by judicial or administrative decision
- Minor and person subject to legal protection: guardianship or curatorship
Key Trial Info
Start Date :
January 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT04784572
Start Date
January 22 2021
End Date
December 31 2024
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ch Ville Evrard
Neuilly-sur-Marne, France, 93330